Charles A. Deignan, Chief Financial Officer at Clearside Biomedical, Inc. (CLSD), sold 14,030 shares at $1.50 ($21K) on 2023-01-19, disclosed to the SEC on 2023-01-20.
Scheduled sale ($21k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CLSD | SELL | 2021-09-23 | $18K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $13K | — | Filing → |
| CLSD | SELL | 2020-06-03 | $28K | — | Filing → |